FDA completes safety review of MS drug

The multiple sclerosis drug fingolimod (Gilenya, Novartis) is now contraindicated for use in patients with certain pre-existing or recent heart conditions or stroke, or who are taking certain antiarrhythmic medications, according to FDA. » More

Continuing Education

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY’S HEADLINES

Facility can’t sell medications for 2 years

Cardinal Health settled litigation with the Drug Enforcement Administration, which suspended Cardinal’s ability to sell controlled-substance medications from its Lakeland, Fla., distribution center for 2 years. » More

Pharmacists help teams improve BP control

Pharmacists included in team-based care improve blood-pressure control for patients, according to new recommendations from the Community Preventive Services Task Force. » More

3 pharmacy schools honored by Educators Challenge

The University of Arizona College of Pharmacy, the University of Maryland School of Pharmacy, and The Ohio State University College of Pharmacy won the first Innovative Adherence Educators Challenge for the best practices in medication adherence teaching. » More

TAKE OUR SURVEY

What are the most important drivers of a successful retail pharmacy leader? Choose all that apply

a) Building a team of "A" type professionals.
b) Staying ahead of the competition with "big picture planning" and "innovation."
c) Focusing on patient outcomes.
d) Focusing on the bottom line.
e) Pushing for perfection.
f) All of the above.

Click here to let us know.

Want to see the results of our last survey about if your employer allows the use of your doctor degree on your name tag? Click here.

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

• Marijuana to treat multiple sclerosis?

• Focus on drug distributors raises questions

• Bonuses don’t improve diabetes care

• Medication adherence: Looking for a leader

Voices

DT Blog: My time as a kiwi apothecary (part 4): Cultural awareness

JP at Large: Pharmacy’s own “1984”

View from the Zoo: Fox in the henhouse

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.